Current insights into cellular determinants of peritoneal fibrosis in peritoneal dialysis: A narrative review

SD Suryantoro, M Thaha, H Sutanto… - Journal of Clinical …, 2023 - mdpi.com
Peritoneal fibrosis is the final process of progressive changes in the peritoneal membrane
due to chronic inflammation and infection. It is one of the main causes of discontinuation of …

Peritoneal fibrosis: from pathophysiological mechanism to medicine

Y Kang, Y Liu, P Fu, L Ma - Frontiers in Physiology, 2024 - frontiersin.org
Peritoneal dialysis (PD) is currently one of the effective methods for treating end-stage renal
disease (ESRD). However, long-term exposure to high concentration glucose in peritoneal …

Circulating galectin-3 level association with cardiovascular risk factors during peritoneal dialysis

X Yang, J Yang, Y Zeng, L Peng, X Liu, J Mo… - Clinical and …, 2024 - Springer
Objective Cardiovascular disease (CVD) represents the primary cause of mortality in
patients afflicted with end-stage renal disease and undergoing peritoneal dialysis (PD) …

[HTML][HTML] 体成分分析水负荷参数对不同模式透析患者预后的影响: 多中心前瞻性队列研究

张东亮, 马迎春, 任建伟, 王磊, 赵景新, 吝许亚 - 中国全科医学, 2024 - chinagp.net
背景维持性血液透析(MHD) 和腹膜透析(PD) 是当前尿毒症患者主要的治疗方式,
如何更好地制订治疗方案解决透析患者水负荷问题一直是临床研究的重要内容 …

Body Composition Analysis of the Effect of Water Load Parameters on Prognosis of Patients with Different Modes of Dialysis: a Multicenter Prospective Cohort Study

D ZHANG, Y MA, J REN, L WANG, J ZHAO… - Chinese General …, 2024 - chinagp.net
Background Maintenance hemodialysis (MHD) and peritoneal dialysis (PD) are main
treatment methods for uremic patients. It remains an important content of clinical research on …

Раздельное и совмещенное проведение стандартного теста перитонеального равновесия (ПЭТ) и мини-ПЭТ

КА Салихова, РП Герасимчук, АБ Сабодаш… - Нефрология и …, 2023 - journal.nephro.ru
Аннотация Цель: оценить возможность проведения двойного мини-ПЭТ (теста
перитонеального равновесия), совмещенного со стандартным. Совмещение позволяет …